IP Library Granted Patent US 10,627,364
Granted Patent B2
US 10,627,364 · App. 14/509,594 · Granted Apr 21, 2020

Systems and methods for biological ion channel interfaces

Inventors: Kenneth L. Shepard (Ossining, NY); Jacob Rosenstein (New York, NY); Siddharth Ramakrishnan (New York, NY); Jared Roseman (New York, NY)
Assignee: The Trustees of Columbia University in the City of New York
G01N27/4148G01N33/48728G01N33/5438H05K3/303Y10T29/49147
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,627,364
App. No.
14/509,594
Granted
Apr 21, 2020
Kind
B2
Abstract

Method for interfacing an integrated circuit with a biological ion channel, the integrated circuit being at least partially disposed within an electrolytic solution and including an amplifier and one or more electrodes on a surface thereof, includes forming one or more microwells proximate the one or more electrodes, applying a lipid membrane over the integrated circuit proximate the microwells, and placing a further electrode in the electrolytic solution proximate the lipid membrane on a side opposite the integrated circuit. A biological ion channel interface is also provided.

Claims (32)

1. A method for interfacing an integrated circuit with a biological ion channel, the integrated circuit being at least partially disposed within a chamber containing an electrolytic solution and including an amplifier and one or more electrodes on a surface thereof, comprising:

forming one or more microwells over the one or more electrodes and the amplifier;

applying a lipid membrane over a bilayer support disposed above the one or more microwells, wherein the lipid membrane and the one or more microwells are disposed within the chamber and further wherein the bilayer support is configured to fuse to the lipid membrane;

placing a further electrode in the electrolytic solution proximate the lipid membrane on a side opposite the integrated circuit, wherein the integrated circuit is formed using a semiconductor process; and

inserting at least one portion of the integrated circuit into a first end of a pipette containing the electrolytic solution, wherein the at least one portion of the integrated circuit includes the amplifier and the one or more electrodes.

2. The method of claim 1 , wherein the lipid membrane comprises a reconstituted lipid bilayer.

3. The method of claim 2 , wherein the lipid bilayer comprises one or more reconstituted lipids in oil.

4. The method of claim 3 , wherein the one or more reconstituted lipids comprise diphytanoyl phosphatidylcholine.

5. The method of claim 3 , wherein the oil comprises n-octane, n-decane or n-hexadecane.

6. The method of claim 1 , wherein the lipid membrane comprises a cellular membrane of a live cell.

7. The method of claim 6 , wherein applying the lipid membrane comprises applying a pressure differential between the live cell and the one or more microwells.

8. The method of claim 7 , further comprising forming microchannels along the integrated circuit proximate the one or more microwells to control the pressure differential proximate the one or more microwells.

9. The method of claim 1 , wherein the one or more electrodes comprise an Ag/AgCl electrode.

10. A biological ion channel interface comprising:

an integrated circuit adapted to be at least partially disposed within a chamber containing an electrolytic solution and comprising an amplifier and one or more electrodes on a surface thereof;

an intermediate structure having one or more microwells formed therein and adapted to be disposed in the electrolytic solution over the one or more electrodes and the amplifier;

a lipid membrane disposed over a bilayer support disposed above the one or more microwells, wherein the lipid membrane and the one or more microwells are disposed within the chamber and further wherein the bilayer support is configured to fuse to the lipid membrane;

a further electrode adapted to be disposed in the electrolytic solution proximate the lipid membrane on a side opposite the integrated circuit, wherein the integrated circuit is formed using a semiconductor process; and

a pipette containing the electrolytic solution, wherein at least one portion of the integrated circuit is disposed in a first end of the pipette, wherein the at least one portion of the integrated circuit includes the amplifier and the one or more electrodes.

11. The interface of claim 10 , wherein the lipid membrane comprises a reconstituted lipid bilayer.

12. The interface of claim 11 , wherein the lipid bilayer comprises one or more reconstituted lipids in oil.

13. The interface of claim 12 , wherein the one or more reconstituted lipids comprise diphytanoyl phosphatidylcholine.

14. The interface of claim 12 , wherein the one or more reconstituted lipids comprise one or more unilamellar lipid vesicles.

15. The interface of claim 12 , wherein the oil comprises n-octane, n-decane or n-hexadecane.

16. The interface of claim 10 , wherein the lipid membrane comprises a cellular membrane of a live cell.

17. The interface of claim 16 , further comprising one or more microchannels disposed along the integrated circuit proximate the one or more microwells to control a pressure differential between the one or more microwells and the live cell.

18. The interface of claim 10 , wherein the one or more electrodes comprise an Ag/AgCl electrode.

19. A method for interfacing an integrated circuit with a biological ion channel, the integrated circuit including one or more electrodes over an amplifier on a surface thereof, comprising:

inserting a portion of the integrated circuit into a first end of a pipette containing an electrolytic solution, wherein the portion of the integrated circuit includes the one or more electrodes and the amplifier and further wherein the integrated circuit is formed using a semiconductor process;

coupling a cell to a second end of the pipette; and

placing an electrical lead wire on a remaining portion of the integrated circuit disposed outside of the pipette, wherein the pipette is configured as a patch pipette for living cells.

20. The method of claim 19 , wherein the pipette comprises a glass patch pipette.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2020
From: SHEPARD, KENNETH L.; ROSENSTEIN, JACOB; RAMAKRISHNAN, SIDDHARTH; ROSEMAN, JARED
To: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
Reel/Frame 052142/0236 →
CONFIRMATORY LICENSE Recorded Sep 25, 2017
From: COLUMBIA UNIV NEW YORK MORNINGSIDE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 043987/0787 →
CONFIRMATORY LICENSE Recorded Oct 30, 2015
From: COLUMBIA UNIV NEW YORK MORNINGSIDE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 037018/0769 →
Continuity (4)
Continuation PCTUS2013031757 · Mar 14, 2013
Provisional Application 61622234 · Apr 10, 2012
Provisional Application 61637111 · Apr 23, 2012
Related Publication 20150090588A1 · Apr 2, 2015